Brind.

Recursion Pharmaceuticals benefits from Trump-era tariffs, reiterated Buy rating from Needham.

1 report, 1 independent Updated Aug 24

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

Donald Trump Recursion (United States)

Keep exploring

The entities involved

Donald Trump
American businessman and politician (born 1946), President of the United States (2017–2021; since 2025)
- Donald Trump plans a rally in Michigan while Barack Obama campaigns for local candidates, and Jocelyn Benson is a gubernatorial candidate.20:22
- Donald Trump criticized Mary Peltola's attendance record, while Dan Sullivan challenges her for the Alaska Senate seat.20:21
Recursion (United States)
company in Salt Lake City, United States

Nothing else this week.

Related events

Donald Trump threatened 200 percent tariffs for a settlement and announced plans for commercial business after a war concludes.Sun 14:10

Coverage

Newest first; wire copies grouped

Aug 24Insider MonkeyNeedham Maintains Buy Rating on Recursion (RXRX) Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) is one of the 10 Best Penny Stocks to Buy for the Next 5 Years. On August 5, Needham reiterated its Buy